LabCorp (LH) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research Published on October 19,2018

LabCorp (LH) might sustain its winning streak in third-quarter 2018 after having retained the same for the past few quarters. However, reimbursement pressure remains a concern.

• MASI Quick QuoteMASIPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• HSIC Quick QuoteHSICPositive Net Change
• LH Quick QuoteLHPositive Net Change

• earnings
• medical

Can Overall Growth Drive Thermo Fisher (TMO) Q3 Earnings?

by Zacks Equity Research Published on October 19,2018

Thermo Fisher's (TMO) steadily strong analytical instrument business flaunts higher global demand.

• TMO Quick QuoteTMONegative Net Change
• MASI Quick QuoteMASIPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• HSIC Quick QuoteHSICPositive Net Change

• earnings
• medical

Will Boston Scientific's (BSX) Q3 Earnings Reflect Overall Gain?

by Zacks Equity Research Published on October 17,2018

We are optimistic about the IC business that will help Boston Scientific (BSX) maintain impressive global growth, owing to an innovative portfolio and robust commercial teams.

• MASI Quick QuoteMASIPositive Net Change
• BSX Quick QuoteBSXPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• HSIC Quick QuoteHSICPositive Net Change

• earnings
• medical

Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings?

by Zacks Equity Research Published on October 16,2018

Abbott (ABT) is consistently well-placed on a healthy growth trajectory within its Diabetes Care business for the past few quarters.

• ABT Quick QuoteABTNegative Net Change
• MASI Quick QuoteMASIPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• HSIC Quick QuoteHSICPositive Net Change

• earnings

Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman

by Zacks Equity Research Published on October 15,2018

Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman

• AXL Quick QuoteAXLNo Net Change
• HUN Quick QuoteHUNPositive Net Change
• MFC Quick QuoteMFCPositive Net Change
• JAZZ Quick QuoteJAZZNegative Net Change
• DVA Quick QuoteDVANegative Net Change

• finance
• medical

5 Low Price-to-Book Stocks to Buy in a Volatile Market

by Zacks Equity Research Published on October 12,2018

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

• AXL Quick QuoteAXLNo Net Change
• HUN Quick QuoteHUNPositive Net Change
• MFC Quick QuoteMFCPositive Net Change
• JAZZ Quick QuoteJAZZNegative Net Change
• DVA Quick QuoteDVANegative Net Change

• insurance
• medical

Zacks.com featured highlights include: Bausch Health, Endava, DaVita, Perspecta and Athene Holding

by Zacks Equity Research Published on October 09,2018

Zacks.com featured highlights include: Bausch Health, Endava, DaVita, Perspecta and Athene Holding

• PRSP Quick QuotePRSPPositive Net Change
• ATH Quick QuoteATHPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• BHC Quick QuoteBHCPositive Net Change
• DAVA Quick QuoteDAVANegative Net Change

• business-services

5 Dirt-Cheap PEG Stocks That Value Investors Love

by Zacks Equity Research Published on October 08,2018

For investors looking to escape value traps, it is vital to determine where the stock is headed in the next 12 to 24 months.

• PRSP Quick QuotePRSPPositive Net Change
• ATH Quick QuoteATHPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• DAVA Quick QuoteDAVANegative Net Change
• BHC Quick QuoteBHCPositive Net Change

• finance
• insurance
• medical
• pharmaceuticals

DVA or CHE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on October 08,2018

DVA vs. CHE: Which Stock Is the Better Value Option?

• DVA Quick QuoteDVANegative Net Change
• CHE Quick QuoteCHEPositive Net Change

• value-stocks
• which-stock-is-cheaper

Are Investors Undervaluing DaVita HealthCare (DVA) Right Now?

by Zacks Equity Research Published on October 08,2018

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

• DVA Quick QuoteDVANegative Net Change

• cheap-stocks
• pe-ratio
• undervalued-stocks
• valuation
• value-stocks

Is DaVita Inc. (DVA) a Great Stock for Value Investors?

by Zacks Equity Research Published on September 25,2018

Is DaVita Inc. (DVA) a great pick from the value investor's perspective right now? Read on to know more.

• DVA Quick QuoteDVANegative Net Change

3 MedTech Stocks for Safe Returns as Hurricane Fears Peak

by Sweta Jaiswal Published on September 21,2018

With the hurricane season at the peak, we bring three safe picks for investors.

• MASI Quick QuoteMASIPositive Net Change
• ISRG Quick QuoteISRGPositive Net Change
• MDT Quick QuoteMDTNegative Net Change
• QDEL Quick QuoteQDELPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• CVS Quick QuoteCVSPositive Net Change
• WBA Quick QuoteWBANegative Net Change

DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand

by Zacks Equity Research Published on September 17,2018

DaVita's (DVA) dialysis care in the United States gets a boost; market prospects solid.

• ATHN Quick QuoteATHNNo Net Change
• MASI Quick QuoteMASIPositive Net Change
• ISRG Quick QuoteISRGPositive Net Change
• DVA Quick QuoteDVANegative Net Change

Here's Why You Should Hold On to DaVita (DVA) Stock Now

by Zacks Equity Research Published on September 12,2018

Strong prospects in the Kidney Care segment to drive DaVita (DVA) stock over the long haul.

• MASI Quick QuoteMASIPositive Net Change
• PEN Quick QuotePENPositive Net Change
• ILMN Quick QuoteILMNNegative Net Change
• DVA Quick QuoteDVANegative Net Change

Kidney Care Demand Shoots Up in US: 3 Stocks Likely to Gain

by Sreyoshi Mukherjee Published on September 06,2018

As the U.S. dialysis industry has been garnering huge profits for decades, some dialysis stocks are worth a look.

• FMS Quick QuoteFMSNegative Net Change
• BAX Quick QuoteBAXNegative Net Change
• DVA Quick QuoteDVANegative Net Change

DaVita HealthCare (DVA) Down 10.2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research Published on August 31,2018

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

• DVA Quick QuoteDVANegative Net Change

DaVita Healthcare Partners' New Facility Now in Los Angeles

by Zacks Equity Research Published on August 22,2018

DaVita's (DVA) incessant efforts to upgrade services, global expansion initiatives and active acquisitions are impressive.

• INGN Quick QuoteINGNPositive Net Change
• ITGR Quick QuoteITGRPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• PDCO Quick QuotePDCOPositive Net Change

DaVita (DVA) Beats Earnings and Revenue Estimates in Q2

by Zacks Equity Research Published on August 02,2018

Year-over-year growth in net dialysis and related lab patient service revenues boost DaVita's (DVA) bottom line in Q2.

• ISRG Quick QuoteISRGPositive Net Change
• SYK Quick QuoteSYKNegative Net Change
• ILMN Quick QuoteILMNNegative Net Change
• DVA Quick QuoteDVANegative Net Change

DaVita HealthCare (DVA) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research Published on August 01,2018

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 8.25% and 0.18%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

• DVA Quick QuoteDVANegative Net Change

Will Revenue, Membership Growth Aid Cigna (CI) Q2 Earnings?

by Zacks Equity Research Published on July 31,2018

Cigna (CI) Q2 earnings is likely to gain from strong growth at its segments.

• CI Quick QuoteCIPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• ESRX Quick QuoteESRXNo Net Change
• PRAH Quick QuotePRAHPositive Net Change

Will a Decline in Membership Mar Aetna's (AET) Q2 Earnings?

by Zacks Equity Research Published on July 31,2018

Aetna (AET) Q2 earnings to suffer from lower membership and revenues partly offset by a lower tax rate.

• AET Quick QuoteAETPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• ESRX Quick QuoteESRXNo Net Change
• PRAH Quick QuotePRAHPositive Net Change

Medical Stock Q2 Earnings Due on Aug 1: ESRX, DVA & HUM

by Zacks Equity Research Published on July 31,2018

Solid R&D prospects likely to drive the healthcare industry in Q2 earnings.

• HUM Quick QuoteHUMPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• ESRX Quick QuoteESRXNo Net Change

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research Published on July 27,2018

DVA vs. CHE: Which Stock Is the Better Value Option?

• DVA Quick QuoteDVANegative Net Change
• CHE Quick QuoteCHEPositive Net Change

Baxter (BAX) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

by Zacks Equity Research Published on July 26,2018

Baxter (BAX) gains on the back of its core Renal Care segment in Q2; solid international sales encourage.

• MASI Quick QuoteMASIPositive Net Change
• ITGR Quick QuoteITGRPositive Net Change
• BAX Quick QuoteBAXNegative Net Change
• DVA Quick QuoteDVANegative Net Change

Can Kidney Care Business Drive DaVita's (DVA) Q2 Earnings?

by Zacks Equity Research Published on July 26,2018

DaVita's (DVA) flagship Kidney Care business likely to drive Q2 results; solid international presence encourages.

• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• DVA Quick QuoteDVANegative Net Change
• COO Quick QuoteCOOPositive Net Change